ANNX Statistics

Total Valuation

Annexin Pharmaceuticals AB has a market cap or net worth of SEK 295.27 million. The enterprise value is 257.92 million.

Market Cap	295.27M
Enterprise Value	257.92M

Important Dates

The next estimated earnings date is Friday, October 18, 2024.

Earnings Date	Oct 18, 2024
Ex-Dividend Date	n/a

Share Statistics

Annexin Pharmaceuticals AB has 532.98 million shares outstanding. The number of shares has decreased by -0.33% in one year.

Shares Outstanding	532.98M
Shares Change (YoY)	-0.33%
Shares Change (QoQ)	-0.26%
Owned by Insiders (%)	48.78%
Owned by Institutions (%)	3.08%
Float	263.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	8.19
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.93
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.39

Current Ratio	7.39
Quick Ratio	7.27
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,006.96

Financial Efficiency

Return on equity (ROE) is -220.41% and return on invested capital (ROIC) is -137.77%.

Return on Equity (ROE)	-220.41%
Return on Assets (ROA)	-101.63%
Return on Capital (ROIC)	-137.77%
Revenue Per Employee	n/a
Profits Per Employee	-13.09M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.31% in the last 52 weeks. The beta is 1.15, so Annexin Pharmaceuticals AB's price volatility has been higher than the market average.

Beta (5Y)	1.15
52-Week Price Change	+25.31%
50-Day Moving Average	0.70
200-Day Moving Average	0.39
Relative Strength Index (RSI)	32.98
Average Volume (20 Days)	792,526

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-52.36M
Pretax Income	-52.36M
Net Income	-52.36M
EBITDA	-52.17M
EBIT	-52.36M
Earnings Per Share (EPS)	-0.19

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	37.35M
Total Debt	n/a
Net Cash	37.35M
Net Cash Per Share	0.07
Equity (Book Value)	36.04M
Book Value Per Share	0.07
Working Capital	34.29M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-51.85M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Annexin Pharmaceuticals AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.33%
Shareholder Yield	0.33%
Earnings Yield	-34.80%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a